Eidos Therapeutics, Inc.

United States of America

Create a watch for Eidos Therapeutics, Inc.
Total IP 19
Total IP Rank # 80,527
IP Activity Score 2/5.0    13
IP Activity Rank # 66,806
Stock Symbol EIDX (nasdaq)
ISIN US28249H1041
Market Cap. 2,900M  (USD)
Industry Biotechnology
Sector Healthcare

Patents

Trademarks

11 0
3 0
5 0
0
 
Last Patent 2025 - Acoramidis for use in the treatm...
First Patent 2018 - Process for preparing ag-10, its...

Latest Inventions, Goods, Services

2025 Invention Acoramidis for use in the treatment of renal dysfunction. Described herein are methods for treati...
2024 Invention Processes for preparing ag-10, its intermediates, and salts thereof. Provided herein are improve...
Invention Methods of treating ttr amyloidosis using ag10. Described herein are methods for treating transt...
Invention Formulations of ag10. The present disclosure provides high-load tablet formulations of AG10 or a...
Invention Potent transthyretin (ttr) stabilization in ttr amyloidosis patients receiving acoramidis. Descri...
2022 Invention Formulations of ag10. The present disclosure provides high-load tablet formulations of AG10 or a ...
2021 Invention Processes for preparing ag-10, its intermediates, and salts thereof. Provided herein are improved...
Invention Methods of treating ttr amyloidosis using ag10. Described herein are methods for treating transth...
2018 Invention Process for preparing ag-10, its intermediates, and salts thereof. Provided herein are improved p...